Since its discovery in 1991, the knowledge about the tumor specific melanoma antigen gene (MAGE-I) family has been continuously increasing. Initially, MAGE-I proteins were considered as selective targets for immunotherapy. More recently, emerging data obtained from different cellular mechanisms controlled by MAGE-I proteins suggest a key role in the regulation of important pathways linked to cell proliferation. This is in part due to the ability of some MAGE-I proteins to control the p53 tumor suppressor. In this review, we focus on the mechanisms proposed to explain how MAGE-I proteins affect p53 functions.Fil: Ladelfa, Maria Fatima. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; A...
Melanoma-associated antigens (MAGE) are expressed in different type of cancers including lung cancer...
Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-family of...
Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer...
Data emerged from the last 20 years of basic research on tumor antigens positioned the type I MAGE (...
The tumor specific melanoma antigen gene (MAGE-I) family was initially considered promising and sele...
The MAGE gene family is characterized by a conserved domain (MAGE Homology Domain). A subset of high...
The p53 tumor suppressor plays a major protective role in tumor prevention by coordinating changes i...
MAGE-A genes are a subfamily of the melanoma antigen genes (MAGEs), whose expression is restricted t...
Normal-to-tumor cell transition is accompanied by changes in gene expression and signal transduction...
Desde su descubrimiento como antígenos en células de melanoma humano, la interpretaciónde las proteí...
<div><p>Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-f...
MAGE-A (Melanoma Antigen Genes-A) are tumor-associated proteins with expression in a broad spectrum ...
To date, dozens of melanoma-associated antigens (MAGEs) have been identified and classified into 2 s...
Abstract The melanoma antigen gene (MAGE) proteins are a group of highly conserved family members th...
MageB2 belongs to the melanoma antigen gene (MAGE-I) family of tumor-specific antigens. Expression o...
Melanoma-associated antigens (MAGE) are expressed in different type of cancers including lung cancer...
Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-family of...
Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer...
Data emerged from the last 20 years of basic research on tumor antigens positioned the type I MAGE (...
The tumor specific melanoma antigen gene (MAGE-I) family was initially considered promising and sele...
The MAGE gene family is characterized by a conserved domain (MAGE Homology Domain). A subset of high...
The p53 tumor suppressor plays a major protective role in tumor prevention by coordinating changes i...
MAGE-A genes are a subfamily of the melanoma antigen genes (MAGEs), whose expression is restricted t...
Normal-to-tumor cell transition is accompanied by changes in gene expression and signal transduction...
Desde su descubrimiento como antígenos en células de melanoma humano, la interpretaciónde las proteí...
<div><p>Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-f...
MAGE-A (Melanoma Antigen Genes-A) are tumor-associated proteins with expression in a broad spectrum ...
To date, dozens of melanoma-associated antigens (MAGEs) have been identified and classified into 2 s...
Abstract The melanoma antigen gene (MAGE) proteins are a group of highly conserved family members th...
MageB2 belongs to the melanoma antigen gene (MAGE-I) family of tumor-specific antigens. Expression o...
Melanoma-associated antigens (MAGE) are expressed in different type of cancers including lung cancer...
Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-family of...
Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer...